AI Science Tracker

Gladstone-UCSF Institute of Genomic Immunology

1 discovery from 2024

Discoveries

CRISPR perturbation and Bayesian network inference map immune-disease regulatory cascades in primary CD4+ T cells

The study used CRISPR knockouts of 84 genes in primary human CD4+ T cells and a new linear latent causal Bayes (LLCB) network-inference method to estimate 211 regulatory connections. Integrating the inferred network with immune GWAS analyses identified an interconnected module in which KMT2A was inferred upstream of JAK-STAT and IL-2 signaling regulators including IRF4, STAT5A/B and IL2RA, linking an epigenetic regulator to immune-disease-associated pathways.

Technology: Linear latent causal Bayes (LLCB), a Bayesian extension of linear latent causal network inference, applied to CRISPR knockout and RNA-sequencing data

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The study used CRISPR knockouts of 84 genes in primary human CD4+ T cells and a new linear latent causal Bayes (LLCB) network-inference method to estimate 211 regulatory connections.
  • Still unknown: The study perturbed 84 selected genes in primary CD4+ T cells from three donors, so this is not a complete T-cell regulatory map. LLCB “direct effects” are statistical effects adjusted for other perturbed genes and are not evidence of physical binding; effects from unperturbed genes can be attributed to modeled edges. The GWAS integration identifies pathway links, not proof that the inferred cascade causes clinical disease. A prior bioRxiv version (10.1101/2023.09.17.557749) is the same study and is not counted separately.
  • AI role: LLCB inferred direct and indirect regulatory relationships from perturbation-associated expression effects across 84 targeted genes. The model-derived network and gene-program analysis, combined with immune GWAS statistics, supported the specific KMT2A-to-JAK-STAT/IL-2 regulatory finding. CRISPR perturbation supplied the experimental perturbation data; the network algorithm converted those measurements into the reported regulatory map.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11605694/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 90 of works of the same type, year and subfield (OpenAlex work metrics, 21 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.